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Abstract
Background:  Diabetes mellitus increases the rate of vaginal colonization and infection with
Candida species
Methods: We surveyed women with diabetes receiving care at either an urban or suburban
diabetes clinic to examine the relationship between vaginal Candida colonization, diabetes type and
duration, and HbA1c level. 101 participants completed the self-administered questionnaire and self-
collected a vaginal swab for Candida culture. Candida colonization was similar by age and race.
Results: Type 1 diabetics were three times as likely as type 2 diabetics to be colonized with any
Candida species (OR = 3.4; 95% CI: 1.03, 11.41; p = 0.04); even after adjusting for abnormal HbA1c,
which had an independent effect (OR = 1.4; 95% CI: 1.04, 1.76; p = 0.02). Recent antibiotic use (OR
= 4.5; 95% CI: 1.18, 16.79; p = 0.03), lifetime history of chlamydia (OR = 5.8; 95% CI: 1.09, 30.54;
p = 0.04), and performing oral sex during the past 2 weeks (OR = 4.9; 95% CI:0.84, 28.27; p = 0.08)
were also associated with Candida carriage after adjusting for diabetic type and abnormal HbA1c. C.
albicans was isolated from the majority of colonized type 1 participants (56%), while C. glabrata was
the most common isolate among colonized type 2 participants (54%).
Conclusions: Improving glucose control and possibly modifying sexual behavior may reduce risk
of Candida colonization, and potentially symptomatic infection, among women with diabetes.
Background
Diabetes mellitus predisposes individuals to bacterial and
fungal infections, including those caused by Candida spe-
cies. Many investigators have suggested that vulvovaginal
candidiasis (VVC) occurs more frequently in diabetics [1–
8]. Further, chronic recurring VVC may be a marker of di-
abetes [9]. Several studies report increased rates of asymp-
tomatic vaginal carriage rates of Candida species and
incidence of symptomatic infection in diabetic women,
but results are inconsistent [5,10–14]. While some show
no increase in carriage of vaginal Candida[5], those dem-
onstrating increased Candida carriage in female diabetes
patients do not examine the effect of glucose control or di-
abetes type [12,14]. However, in vitro studies demonstrat-
ing impaired host response directed against Candida in
diabetics support the idea of increased rates of Candida
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colonization among diabetics [4,6,7]. Whether diabetes
leads to more symptomatic and/or more recurrent VVC
episodes is a subject of controversy.
Potential risk factors for VVC include diabetes type, sever-
ity, and degree of glucose control.[26–30] In addition to
diabetes mellitus, a number of VVC risk factors have been
identified, including African-American heritage [15–17],
previous history of VVC [15], higher education degree, in-
termediate age, oral contraceptive pills [3,10,16,18], use
of commercially available solutions for cleansing of exter-
nal genitalia or vaginal douching, frequent sexual inter-
course [17,19,10], sexual behavior (age at first intercourse,
frequency of oral-genital contact) [20], contraception de-
vices (diaphragm, vaginal contraceptive sponge, intrauter-
ine device), and antibiotics [3,15,19]. Whether these
factors increase risk ofCandida colonization or sympto-
matic infection following colonization, or both, is un-
known, however, it should be emphasized that a pre-
requisite for symptomatic vaginitis is vaginal colonization.
Few studies have addressed the relationship between Can-
dida colonization, VVC, and diabetes; none we are aware
of have examined the role of behavioral VVC risk factors
for colonization among persons with diabetes. To evalu-
ate the relationship between Candida colonization and
hypothesized risk factors for vulvovaginal candidiasis col-
onization in diabetics, we conducted a cross-sectional
study among female diabetes patients receiving care at
one of two diabetes clinics. We describe the associations
between  Candida colonization, sociodemographics,
health behaviors, diabetes type, diabetes severity, and He-
moglobin A1c level among women with type 1 and type 2
diabetes.
Methods
Study population
Female diabetes patients seen at an outpatient academic
diabetes practice of Wayne State University Division of
Endocrinology, Department of Internal Medicine, were el-
igible for study. The practice included an urban (Universi-
ty Health Center, Detroit, MI) clinic and a suburban clinic
(Hechtman Clinic, Bingham Farms, MI). Patients were di-
agnosed with type 1 and type 2 diabetes on clinical pres-
entation by a board certified endocrinologist. Potential
participants were approached in the clinic waiting room
and consent obtained. As an incentive for participation,
subjects were rewarded with video rental gift certificates
(value $5). Participants consented to a medical record re-
view which included abstraction of total glycated hemo-
globin levels obtained at the enrollment visit, completed
a self-administered questionnaire and self-collected a vag-
inal swab. The questionnaire addressed the following var-
iables: sociodemographic (age, race, marital status,
insurance status, highest education completed, occupa-
tion); diabetes duration, type, severity, and abnormal glu-
cose level; lifetime history of physician diagnosed VVC
episodes; recent antibiotic use, by type; sexual history;
health behaviors. For the diabetes section we used ques-
tions from the Diabetes Care Profile, an instrument devel-
oped and validated by the Michigan Diabetes Research
and Training Center [21,22]. The study protocol was ap-
proved by the Institutional Review Boards at the Universi-
ty of Michigan and Wayne State University.
Of 155 women approached, 105 (67.7%) consented. One
woman was ineligible because her vaginal sample was
lost. Two women decided to stop participating during the
study; one did not understand the questionnaire, while
the other felt the questionnaire was too intrusive, leaving
a final sample size of 101 participants.
Laboratory methods
All vaginal specimens were cultured for yeast. Specimens
were placed on plates with media selective for Candida
growth (Sabouraud's dextrose agar). Suspected mixed
samples, as determined by colony type and microscopic
characteristics, were placed on plates with media showing
species-specific colony color change (Chromagar, CHRO-
Magar, Paris, France). C. albicans and C. glabrata were
identified by chlamydospore and germ tube tests; all other
species were identified by carbohydrate assimilation tests
(API-20C AUX).
Data analysis
We described the distributions of hypothesized variables
among participants, using simple descriptive statistics,
and the associations between hypothesized risk factors
and  Candida colonization using odds ratios (OR) and
Cornfield 95% confidence intervals (CI). After a detailed
stratified analysis, to assess confounding and effect modi-
fication, we fit a logistic regression model for Candida car-
riage. We calculated ORS and 95% CIs for the bivariate
analyses using EpiInfo [23]; all other analyses and data
management were done using SAS [24]. Several variables
strongly associated with Candida colonization had small
numbers of missing values, particularly for oral sex (13%)
and douching (9%) (others did not exceed 5%). In this
case, for the multivariate analyses, we inferred that a miss-
ing response was equivalent to a negative response. If we
are wrong in this inference, the resulting estimates will be
biased towards the null hypothesis of no effect. Excluding
the missing responses from the relevant analyses only
modestly changed the point estimates.
Results
Demographic characteristics by clinic
Fifty-nine participants were recruited from UHC; forty-
two were recruited from Hechtman. Mean age among
UHC participants was 52.3 years, while mean age amongBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/1
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Hechtman participants was 50.0 years (p = 0.5). The clin-
ics varied greatly, however, in participant ethnicity. Forty
of fifty-nine (67.8%) UHC participants were of African
American descent. By contrast, eight of 42 (19.0%) Hech-
tman participants were of African American descent.
Diabetes characteristics
Most participants had type 2 diabetes (62/101 = 61%). By
clinic, type 2 was more common among UHC participants
(69%), but was equally distributed among Hechtman par-
ticipants.
Total glycated hemoglobin levels measured at the time of
the enrollment visit were abstracted from patient's charts.
We assessed glycemia by transforming total glycated he-
moglobin levels to hemoglobin A1c (HbA1c) values using
a linear regression formula [25]. For the Wayne State Uni-
versity patient population, a value of HbA1c > 6.4% is ab-
normal. This cutpoint was determined by standard
clinical laboratory comparison methods and verification
of the reference interval [26–30]. The mean HbA1c for our
study population was 7.91, with a range of 4.4–15.7.
Overall, only 20 of 101 participants (19.8%) had normal
HbA1c at time of enrollment. Type 1 subjects had a higher
proportion of abnormal levels (92.3%) than type 2 sub-
jects (72.6%) (p = 0.02).
Correlates of Candida colonization
29 of 101 (28.7%) participants were colonized with Can-
dida species. 2 of the 29 (6.9%) were colonized with two
Candida species. The most common species were C. albi-
cans (12/29 = 41.4%) and C. glabrata (11/29 = 37.9%). C.
albicans predominated among women with type 1 (9/16
colonized or 56%) and C. glabrata among women with
Type 2 (7/13 colonized or 54%). We identified one isolate
of C. parapsilosis, C. guilliermondii, and Trichosporon beigelli.
Type 1 patients were more likely to be colonized with
Candida than type 2 patients (OR = 2.6; 95% CI: 0.99,
6.98; p = 0.03) (Table 1). Women with abnormal HbA1c
were almost three times more likely to be colonized with
Candida than those with normal HBA1c, but this associa-
tion was not statistically significant (OR = 2.7; 95% CI:
0.68, 15.39; p = 0.13). No statistically significant associa-
tion was detected between Candida colonization and du-
ration of diabetes, although those who were colonized in
each diabetic type tended to have longer duration of dia-
betes (mean duration diabetes, colonized v. not: type 1:
15.7 v. 20.2 y, p = 0.34; type 2: 9.8 v. 16.1 y, p = 0.28). Av-
erage duration of diabetes among colonized women did
not differ by type (type 1: 20.2 v. type 2: 16.1; p = 0.53).
Age, race, marital status, education, and employment
were not significantly associated with Candida coloniza-
tion (Table 1). Antibiotic use in the past 2 weeks, lifetime
history of chlamydia, douching, and report of both per-
forming and receiving oral sex in the last two weeks were
strongly associated with Candida colonization, whereas
vaginal-penile sex had only a modest and not statistically
significant assocation with Candida colonization. When
stratified by oral sex, there was no association between
vaginal sex and colonization status. However, the effect of
oral sex remained after stratification by vaginal sex.
Multivariate Analyses
To simultaneously adjust for variables independently as-
sociated with Candida colonization in the crude analyses,
we fit a logistic regression model predicting Candida car-
riage (Table 2). Because of the small sample size, we cre-
ated a base model including age, diabetes type, abnormal
HbA1c, recent antibiotic use, and performing oral sex. We
assumed for this analysis that those who did not respond
to questions about oral sex did not engage in oral sex. Re-
ceiving oral sex was not associated after adjustment for
performing oral sex (OR = 1.07; 95 % CI: 0.12, 9.42, p =
0.95) and thus was excluded from the base model. Other
variables associated in the bivariate analyses were added
one at a time to the base model. After adjustment, older
age, having type 1 diabetes, an abnormal HbA1c level, and
report of antibiotic use during the previous 2 weeks were
statistically significantly associated with Candida coloni-
zation. Performing oral sex was associated with an almost
fivefold increase in colonization, but the association was
not statistically significant (p = 0.08). When added indi-
vidually to the base model, lifetime history of chlamydia
(OR = 5.8; 95% CI: 10.9, 30.54) but not douching (OR =
2.2; 95 % CI: 0.68, 7.00) remained strongly associated
with colonization. Four participants positive for Candida
also had a previous chlamydia diagnosis and reported
douching. When entered simultaneously into the model,
the estimates were unstable, thus, they were entered sepa-
rately. Douching and history of chlamydia were also
strongly associated with performing oral sex; adding each
of these variables reduced the parameter estimate and sta-
tistical significance of the association with performing
oral sex. Pregnancy history had no association with colo-
nization after adjustment (OR = 0.97; 95% CI:0.26, 3.66).
Discussion
Among women with diabetes, Candida carriage increased
with older age, type 1 diabetes, abnormal HbA1c level,
oral antibiotic use in the previous two weeks, and ever his-
tory of chlamydia. Other VVC risk factors, including Afri-
can American descent, lifetime history of VVC, higher
education, oral contraceptive use, and frequency of vagi-
nal intercourse were not significantly associated with Can-
dida colonization after adjustment for other variables.
These data suggest that behavioral factors, as well as
HbA1c, are important determinants of Candida coloniza-
tion among women with diabetes.BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/1
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Table 1: Association of Candida colonization with host characteristics among 101 women with diabetes recruited from urban and sub-
urban clinics (2000)
Not Colonized Colonized
Characteristic Number Number OR 95% CI p-value
Diabetes Type
Type 1 23 16 2.62 (0.99, 6.98) 0.03
Type 2 49 13
Hemoglobin A1c
+
Normal (4–6.4%) 17 3
Abnormal (> 6.4%) 55 26 2.68 (0.68, 15.39) 0.13
Duration (miss = 5)
< 5 years 24 9
6–14 years 26 4 0.41 (0.08,1.74) 0.17
> 14 years 19 14 1.96 (0.63, 6.32) 0.20
Age
18–44 24 7
45–59 21 15 2.45 (0.75, 8.45) 0.10
60+ 27 7 0.89 (0.23, 3.46) 0.85
Race (miss = 1)
White 38 13
Black 32 15 1.37 (0.52, 3.64) 0.48
Asian 1 1 2.92 (0.03, 234.35) 0.44
Marital Status (miss = 6)
Never married 11 6
Married, living with spouse 30 12 0.73 (0.19,3.00) 0.61
Married, not living with 5 2 0.73 (0.05, 6.55) 0.75
spouse; and/or separated
Widowed or divorced 22 7 0.58 (0.13,2.69) 0.42
Education (miss = 4)
High school or less 25 6
Vocational/Associate/ Some college 26 15 2.40 (0.72, 8.72) 0.11
Bachelor's degree and higher 19 6 1.32 (0.30, 5.78) 0.67
Employed (miss = 8)
Not employed 30 15
Part-time 14 3 0.43 (0.07., 1.91) 0.22
Full-time 22 9 0.82 (0.26, 2.44) 0.69
Insurance (miss = 10)
No 0 3
Yes 64 24 -- (0.0, 0.98) 0.02*
Antibiotics (oral only)
None 65 20
Taken in last two weeks 7 9 4.18 (1.19, 14.84) 0.01*
Lifetime history of Chlamydia (miss = 5)
No 65 23
Yes 3 5 4.71 (0.83,32.12) 0.04*
Douche (miss = 9)
No 48 15
Yes 17 12 2.26 (0.79, 6.37) 0.09
Oral sex in past 2 weeks (miss = 13)
None 58 17
Perform only 1 1 3.41 (0.04,272.31) 0.42*
Receive only 3 1 1.14 (0.02, 15.23) 1.00*
Perform and Receive 2 5 8.53 (1.22,93.93) 0.02*
Vaginal-penile sex in past 2 weeks (miss = 
8)
None 45 22
Yes 15 11 1.50 (0.53,4.17) 0.39
+Note: HbA1c calculated from a linear regression formula using total glycated hemoglobin values. Cut points based on local laboratory values. *2-
tailed Fisher's Exact TestBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/1
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Women with type 1 diabetes had higher Candida coloni-
zation rates than those with type 2, even after adjusting for
age, behavioral factors and HbA1c. One possible explana-
tion is difference in duration of Candida carriage: women
with type 1 and type 2 diabetes may be equally likely to
acquire Candida, but those with type 1 may be less able to
clear it. Similar to previous reports, C. albicans was isolat-
ed from the majority of colonized type 1 participants,
while C. glabrata was the most common isolate in type 2
participants, but our numbers are small [1]. Whether this
is due to diabetes type or reflects different distributions of
Candida species by age or both is uncertain.
The observation that hyperglycemia in type 1 diabetes in-
creases risk for Candida colonization is consistent with
previous reports [1,5,6,31]. A New Zealand study of 124
women with type 1 diabetes found 7 of 7 women with el-
evated glycated hemoglobin reported vaginal symptoms
for the previous year, compared with 60% overall [10].
Hyperglycemia limits neutrophil function among persons
with type 1 diabetes, including neutrophils' ability to
phagocytose and kill Candida organisms. With the oxida-
tive killing ability of neutrophils hindered, diabetics may
not be able to clear pathogens as well as non-diabetics
[1,6,7,31]. Hyperglycemic individuals may also have in-
creased risk for Candida colonization because their secre-
tions contain glucose, which can serve as nutrients for
Candida organisms. Sobel and colleagues reported a fu-
cose (6-deoxy-galactose) vaginal epithelial cell receptor
that aids in adhesion of Candida to vaginal epithelial cells
[32]. Since fucose contains an isomer of glucose and acts
as one form of receptor site for Candida adhesion, it is pos-
sible that increased Candida colonization is proportional
to glucose level. Receptor avidity may be a reflection of in-
creased glucose levels in the blood and tissues. Glycemia,
however, does not fully explain the observed increased
risk of Candida colonization.
We found a borderline significant association with per-
forming oral sex associated with an almost five-fold in-
crease in vaginal colonization with Candida. Receiving but
not performing oral sex has been previously reported as a
risk factor for VVC [15]. Oral sex may facilitate transmis-
sion of yeast, as Candida often colonizes the oral cavity
[15,33]. Diabetics may be more likely to carry Candida in
the oral cavity than their sex partner; thus, performing oral
sex on their sex partner prior to vaginal intercourse may
serve to inoculate the vaginal cavity. Douching has also
been previously associated with Candida colonization
[17,19,20]. The practice is hypothesized to disrupt vaginal
flora; vaginal symptoms may also lead a women to
douche so the direction of effect is unclear. The associa-
tion we observed with chlamydia is probably a marker of
sexual behavior rather than a causal factor; for example,
women who reported a history of chlamydia were more
likely to douche and to report engaging in oral sex, al-
though it is possible that chlamydia carriage adversely af-
fects the vaginal flora increasing the chance of Candida
colonization. Recent antibiotic use is a well-described cor-
relate of symptomatic Candida vaginitis [3,15–18,34].
While asymptomatic infection is not equivalent to dis-
ease, antibiotic use may act to alter the vaginal microenvi-
ronment to facilitate Candida colonization in the same
way it is hypothesized to promote VVC.
Women aged 45 years and older in our study were more
likely to be colonized with Candida species. We are una-
ware of colonization studies in women of comparable
age; most have emphasized women of childbearing age
[8,35,36]. Whether our observation is a real finding or a
reflection of our age distribution (18–84) or unknown se-
lection biases which led to inclusion in our study requires
further investigation. However, incidence of symptomatic
infection is higher in younger (18–44) women [15].
Table 2: Logistic regression models predicting Candida colonization among 101 women with type 1 or type 2 diabetes (2000)
Variable Name Parameter
Estimate
p-value Odds Ratio (95% CI)
Age 45 and older 1.92 0.008 6.8 (1.64, 28.37)
Diabetes type 1 -1.23 0.04 3.4 (1.03, 11.41)
Glycemia (% HbA1c)* 0.30 0.02 1.36 (1.04,1.76)
Antibiotics in past 2 weeks (oral only) 1.49 0.03 4.5 (1.18, 16.79)
Perform oral sex in past 2 weeks 1.59 0.08 4.9 (0.84, 28.27)
Douche 0.78 0.19 2.2 (0.68, 7.00)
Lifetime history of chlamydia 1.75 0.04 5.8 (1.09,30.54)
* HbA1c (%) > 6.4. HbA1c calculated from a linear regression formula using total glycated hemoglobin values. Cut points based on local laboratory 
values. NOTE: All models included age, diabetes type, HbA1c, antibiotic use, and oral sex.BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/1
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This study is small and was intended to be hypothesis gen-
erating. The study population is in no way representative
of all females with diabetes, although the age and racial
distribution of participants reflected that of the participat-
ing clinics. Although it is possible that women with a his-
tory of symptomatic infection might have been more
likely to participate, we have no reason to believe that
women differentially participated by both symptomatic
history and other variables under study which would have
biased our results. Further, as women were unaware of
whether they carried Candida at the time of completing
the questionnaire, it seems unlikely that a differential re-
call of behaviors among colonized and non-colonized
might have occurred. A final concern is that Candida colo-
nization, while the first step toward VVC, is not equivalent
to symptomatic infection. Larger, more definitive studies,
which include a non-diabetic control group and prospec-
tive follow-up, are planned.
Conclusions
We found strong, statistically significant associations be-
tween vaginal Candida colonization and antibiotic use,
lifetime history of chlamydia, diabetes type and HbA1c
level and a borderline significant association with per-
forming oral sex. More non-albicans species were observed
among women with type 2 diabetes. Improving glucose
control and possibly modifying sexual behavior may re-
duce risk of Candida colonization, and potentially symp-
tomatic infection, among women with diabetes.
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